CRC tissues; paracancerous normal tissues; blood samples; serum exosomes
HCT116; LOVO; SW480; FHC
cell line-derived xenograft
ceRNA regulation (promotes); proliferation (promotes); migration (promotes); invasion (promotes); metastasis (promotes); apoptosis (inhibits); other pathway/process (promotes)
RNase R Treatment; RT-qPCR; Nuclear-Cytoplasmic Fractionation; Clinical Sample Validation; Luciferase Reporter Assay; Transfection; CCK8; Colony Formation Assay; Transwell Assay; Annexin V/PI Flow Cytometry; Western Blot; IHC (Immunohistochemistry); In Vivo Animal Model; Survival Analysis; Bioinformatics Analysis
High circ_0005615 expression was associated with lymph node metastasis, TNM stage, tumor size, and poor survival rate; circ_0005615 might be a novel diagnostic biomarker for CRC and a possible therapeutic target through the circ_0005615/miR-873-5p/FOSL2 axis.
circ_0005615 is up-regulated in CRC tissues, CRC cell lines, and serum exosomes from CRC patients. It promotes malignant CRC progression by sponging miR-873-5p and increasing FOSL2 expression, thereby enhancing proliferation, migration, invasion, metastasis, and tumor growth while suppressing apoptosis. High circ_0005615 expression is associated with adverse clinicopathological features and poor survival, suggesting biomarker and therapeutic relevance.
0.8069
Circ_0005615 Regulates the Progression of Colorectal Cancer Through the miR-873-5p/FOSL2 Signaling Pathway.
combined biological and clinical study